Work

A reproducibility-audit framework for generalizable versus dataset- specific molecular transition boundaries in Alzheimer’s disease

Year: 2026
Type: preprint
Abstract: Summary Molecular staging of Alzheimer’s disease (AD) increasingly defines transition boundaries along single-cell pseudo-progression trajectories, yet whether such boundaries reproduce across brain regions, cohorts and molecular modalities is rarely tested. We present a permutation-controlled audit that combines nine boundary-detection algorithms with a fixed marker panel and four orthogonal reproducibility axes—algorithmic consensus, region, cohort and modality. On synthetic data with planted ground-truth boundaries the audit reaches 100% sensitivity and 94% specificity, rejecting four distinct artefact classes each by a different axis. Applied to the Seattle Alzheimer’s Disease Brain Cell Atlas middle temporal gyrus, it localizes a transition that is robust across algorithms and recovered in most cell types but does not generalize: its leading marker is attenuated or absent in prefrontal cortex, entorhinal cortex and cerebrospinal fluid, and an apparent cross-region conservation of glial metabolic genes proves to be a global-expression offset rather than a shared program. The same audit nonetheless certifies an externally validated marker (astrocytic PTGDS) as reproducible across regions and modalities, showing that it separates generalizable anchors from dataset-specific ones rather than rejecting all signals. We provide this four-axis audit as a transferable, code-available standard to apply before a trajectory boundary is read as a biological stage, in AD and other progressive proteinopathies. Highlights A four-axis audit tests whether AD molecular-staging boundaries reproduce On synthetic ground truth it reaches 100% sensitivity and 94% specificity A robust MTG transition fails to generalize across regions, cohorts and CSF Apparent cross-region metabolic conservation is a global-expression artefact In brief Kim et al. develop a permutation-controlled, multi-algorithm audit that tests whether molecular transition boundaries in Alzheimer’s disease reproduce across regions, cohorts and modalities. Validated on synthetic ground truth, the audit separates a generalizable anchor (PTGDS) from a dataset-specific signal and a global-expression artefact, providing a reusable control for trajectory-based molecular staging. Motivation Single-cell atlases increasingly place disease stages at molecular transition boundaries along pseudo-progression trajectories, and the marker that anchors such a boundary is often read as biologically meaningful. Yet a boundary identified in one atlas need not recur in another region, cohort or molecular modality, and a large single-dataset effect can reflect global transcriptional amplitude rather than a specific program. No standard procedure exists to decide whether a trajectory boundary generalizes before it is interpreted. We therefore built a transferable, permutation-controlled audit with measurable operating characteristics that makes this decision explicit, and asked what it implies for one widely used atlas.
Language: English
Open Access status: green
OpenAlex ID: W7204884322
Cites: 1
Cited by:
Related to: 10